LLY
748.51
-1.17%↓
JNJ
152
+0.47%↑
UNH
302
+3.69%↑
ABBV
183.75
-0.11%↓
NVO
66.05
+2.66%↑
LLY
748.51
-1.17%↓
JNJ
152
+0.47%↑
UNH
302
+3.69%↑
ABBV
183.75
-0.11%↓
NVO
66.05
+2.66%↑
LLY
748.51
-1.17%↓
JNJ
152
+0.47%↑
UNH
302
+3.69%↑
ABBV
183.75
-0.11%↓
NVO
66.05
+2.66%↑
LLY
748.51
-1.17%↓
JNJ
152
+0.47%↑
UNH
302
+3.69%↑
ABBV
183.75
-0.11%↓
NVO
66.05
+2.66%↑
LLY
748.51
-1.17%↓
JNJ
152
+0.47%↑
UNH
302
+3.69%↑
ABBV
183.75
-0.11%↓
NVO
66.05
+2.66%↑
24u
Huidig
Min
1.77
Max
1.8
Aanbevelingen | Buy |
---|---|
12 Maanden Prognose | +783.98% upside |
Volgende Winsten | 11 aug 2025 |
---|
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
10 mrt 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Lezen
10 mrt 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Lezen
10 mrt 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Lezen
10 mrt 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Lezen
10 mrt 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Lezen
10 mrt 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lezen
10 mrt 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lezen
Prijswijziging
By TipRanks
12 Maanden Prognose
Gemiddelde 16 USD 783.98%
Hoogste 16 USD
Laagste 16 USD
Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Fortress Biotech Inc - Dist. in de afgelopen 3 maanden.
By TipRanks
Buy
1 ratings
1
Buy
0
Hold
0
Sell
Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Fortress Biotech Inc - Dist in de afgelopen 3 maanden.
$